Federal Law Flashcards
1
Q
What are exceptions to dispensing medications in child-resistant packaging
A
- Patient requests non-child-resistant packaging.
- Physician requests non-child-resistant packaging.
- Sublingual dosage forms of nitroglycerin.
- Sublingual and chewable forms of isosorbide dinitrate in dosage strengths of 10 mg or less.
- Erythromycin ethylsuccinate granules for oral suspension
- Cyclically administered oral contraceptives in manufacturers’ mnemonic (memory-aid) dispenser and conjugated estrogen
- Anhydrous cholestyramine in powder form.
- Potassium <50mEq/unit dose
- Sodium fluoride containing not more than 110 milligrams of sodium fluoride (the equivalent of 50 mg of elemental fluoride) per package or not more than a concentration of 0.5 percent elemental fluoride.
- Betamethasone tablets packaged in manufacturers’ dispenser packages, containing no more than 12.6 mg
- Pancrelipase preparations in tablet, capsule, or powder form.
- Prednisone in tablet form, when dispensed in packages containing no more than 105 mg.
- Mebendazole in tablet form in packages containing not more than 600 mg.
- Methylprednisolone in tablet form in packages containing not more than 84 mg.
- Colestipol in powder form in packages containing not more than 5 grams of the drug.
- Erythromycin ethylsuccinate tablets in packages containing no more than the equivalent of 16 grams erythromycin.
- Norethindrone Acetate Tablets, U.S.P., when dispensed in mnemonic packages containing not more than 50 mg of the drug.
- Medroxyprogesterone acetate tablets.
- Sacrosidase (sucrase) preparations in a solution of glycerol and water.
- Hormone Replacement Therapy Products that rely solely upon the activity of one or more progestogen or estrogen substances.
- Products intended for topical application.
- Products in dosage forms not intended for oral administration.
2
Q
What must a pharmacist do prior to dispensing easy-cap medication bottles?
A
Have the patient sign “notice of none-child resistant packaging”
